Biotechnology firm Akadeum Life Sciences announced the closing of a $20 million financing round that will enable the company to advance its CGT product suite. Michigan Capital Network led the investment alongside contributions from Arboretum Ventures, NYBC Ventures, and other investors. The funding follows the launch of the firm’s GMP-compliant product launch and will be…

Companies that address individuals’ nonmedical social needs such as food insecurity, transportation, isolation and loneliness, are carving out a place in the healthcare market. Many of these companies work with health plans to serve hard-to-reach, vulnerable populations, and, as these startups grow, there are opportunities to combine capabilities to extend their reach. READ MORE

Rio Rancho, New Mexico-based NTx Bio will establish a biomanufacturing facility in Plano, creating more than 170 new jobs and more than $31 million in capital investment, Gov. Greg Abbott announced. A Texas Enterprise Fund (TEF) grant of nearly $1.5 million has been extended to NTx Bio, also known as Nature’s Toolbox Inc. Founded in…

SCOTTSDALE, Ariz., May 1, 2025 /PRNewswire/ — CND Life Sciences, Inc. (CND) announced today that it has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most recent Series A3 offering. The company’s strong growth has been fueled by its innovative Syn-One Test® that uses skin biopsy tissue to detect…

LAGUNA HILLS, Calif., Feb. 12, 2025 /PRNewswire/ — Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced a partnership with Hannah Storm, an Emmy award-winning sports broadcaster, producer and director. Storm, who was diagnosed with ductal carcinoma in situ (DCIS), also known at stage 0 breast cancer, in early 2024, is…

LAGUNA HILLS, Calif., Jan. 16, 2025 /PRNewswire/ — Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation for its DCISionRT® test. READ MORE

TEMPE, Ariz., Jan. 16, 2025 /PRNewswire/ — GT Medical Technologies, Inc. (GT MedTech), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced the company has completed a $37 million first close of a Series D financing round. READ MORE

RIO RANCHO, N.M., January 09, 2025–(BUSINESS WIRE)–Nature’s Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the full commercial availability of NTxscribe®, a benchtop, continuous flow RNA in vitro transcription (IVT) and purification system that brings cost effective and scalable RNA manufacturing to the market. READ MORE

BOSTON, Oct. 1, 2024 – Elucid has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PlaqueIQ™ imaging analysis software to help physicians diagnose cardiovascular disease (CVD). PlaqueIQ is the first FDA-cleared non-invasive software that can objectively quantify and classify plaque morphology based on ground-truth histology, the gold…

GT Medical Technologies, maker of the GammaTile bioresorbable collagen tile, announced that it secured a $35 million venture loan facility. Within the loan facility, Horizon Technology Finance Corporation, an affiliate of Monroe Capital, funded an initial $15 million. In addition to Horizon, the company has backing from a number of top-tier investors. That list includes MVM…

RIO RANCHO, N.M.–(BUSINESS WIRE)–Nature’s Toolbox, Inc. (NTx), a life sciences company building next generation platforms to manufacture RNA and protein, announced today that it has raised $47.5M in Series B financing. Led by RA Capital Management, the investment will fuel the advancement of the company’s biomanufacturing platforms, NTxscribe® and NTxpress®. Acceleration of these technology foundations…

MINNEAPOLIS–(BUSINESS WIRE)–Pyx Health, a tech-enabled services company that provides health plans and their members an innovative, scalable solution that uniquely reduces loneliness and social isolation, today announced a majority growth investment from TT Capital Partners (TTCP). The company’s innovative app-based technology, paired with timely human interventions, improves patient and member outcomes in vulnerable populations, reduces…

MINNEAPOLIS–(BUSINESS WIRE)–Pyx Health, a tech-enabled services company that provides health plans and their members an innovative, scalable solution that uniquely reduces loneliness and social isolation, today announced a majority growth investment from TT Capital Partners (TTCP). The company’s innovative app-based technology, paired with timely human interventions, improves patient and member outcomes in vulnerable populations, reduces…

BOSTON, June 22, 2022 /PRNewswire/ — Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round.  The round was led by an undisclosed strategic investor, with participation from Biovision Ventures, a new Europe-based fund, and existing investors, including MedTex Ventures,…

LAGUNA HILLS, Calif., March 22, 2022 /PRNewswire/– Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that it has closed a $20 million funding round led by Evidity Health Capital and joined by existing and new investors. Alejandro Sanchez, Managing Director of Evidity Health Capital, will be…

Tempe, Arizona – GT Medical Technologies has created a new way to target brain tumors like the type that took the late Senator John McCain’s life. GammaTile technology, invented and developed in Arizona, consists of four tiles implanted in a patient. These tiles contain dosages of radiation that targets glioblastomas. We’ll get more from Dr. David…

Tempe, Arizona –Listen to The Health Technology podcast from UCSF Rosenman Institute to hear GT Medical Technologies, Inc. CEO Matt Likens share how GammaTile Therapy challenges the current standard of care for patients with recurrent brain tumors by improving quality of life and delaying time to recurrence for all tumor pathologies (gliomas, meningiomas, metastases, etc.). LISTEN HERE

Tempe, Arizona & San Diego, California – BlueStone portfolio company GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced that Peter Nakaji, M.D., GT MedTech’s co-founder and director of the Neurosurgery Residency Program at Barrow Neurological Institute in Phoenix, has been selected by the American Association of Neurological…

Tempe, Arizona & Minneapolis, Minnesota –  University of Minnesota Health (M Health) is the first health system in the United States to begin offering GammaTile Therapy™, a new approach to treating recurrent brain tumors. GammaTile Therapy is an FDA-cleared, surgically targeted radiation therapy (STaRT™) that is designed to delay tumor regrowth for patients with brain tumors.…

Minneapolis, Minnesota –  It sounds like science fiction, but doctors at University of Minnesota Health are the first in the country to offer an implantable form of radiation to target brain cancer. The implant is called GammaTile Therapy and Linda Tinega was the first patient in Minnesota to receive it.  “Each tile, has four, radioactive seeds on…